Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

59.96 +0.95 (+1.61%)
Official Closing Price Updated: 7:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
Where Does Hims & Hers Stock Go From Here?
Is Hims & Hers in trouble since the FDA put a time clock on some GLP-1s, or is the future still bright? 
Via The Motley Fool
Exposures Product Safety
CVS Has 'Real Value,' Jim Cramer Says: Micron Had An 'Amazing' Quarter
Via Benzinga
CVS Health Positioned For Medicare Margin Expansion And Market Share Gains, Says Barclays Analyst
Barclays upgrades CVS Health to Overweight, citing gains in pharmacy market share and potential upside from CostVantage. CVS is expected to recover 200 basis points in Medicare margins by 2026,... 
Via Benzinga
What the Options Market Tells Us About CVS Health
Via Benzinga
This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Via Benzinga
Looking Into CVS Health's Recent Short Interest
Via Benzinga
Looking At CVS Health's Recent Unusual Options Activity
Via Benzinga
Unpacking the Latest Options Trading Trends in CVS Health
Via Benzinga
What Analysts Are Saying About CVS Health Stock
Via Benzinga
Bernie Sanders And AOC Clap Back At Mark Cuban's Push for FCC Chief Shakeup: 'Anyone Goes Near Lina Khan And There Will Be An Out And Out Brawl'
Alexandria Ocasio-Cortez and Bernie Sanders have strongly defended FTC chief Lina Khan and opposed Mark Cuban's suggestions that she be replaced if Kamala Harris becomes president. 
Via Benzinga
Exposures Regulatory
CVS, UnitedHealth Request FTC Chair Recusal Amid Ongoing Pharmacy Benefit Managers Lawsuit
The FTC has filed a formal complaint accusing CVS, Cigna, and UnitedHealth of engaging in anti-competitive practices that inflate insulin prices. The complaint claims the PBMs' focus on rebates raises... 
Via Benzinga
Biotech Stocks Poised For Another Big Move In Q4
The healthcare sector can be a safe haven if volatility increases. 
Via Talk Markets
Does This New Development Make CVS Stock a Buy or a Sell?
Major changes could soon be coming, but will they drive the stock up? 
Via The Motley Fool
Billionaire Investor Pushes for Changes at CVS. Is Now the Time to Buy the Stock?
The stock could be poised for a turnaround. 
Via The Motley Fool
Stock Of The Day: Is It Time To Sell CVS?
The chart of CVS (CVS) shows two important market principles. There tends to be resistance at former peaks and support at former bottoms. 
Via Benzinga
CVS Health's Options: A Look at What the Big Money is Thinking
Via Benzinga
Spotlight on CVS Health: Analyzing the Surge in Options Activity
Via Benzinga
An Activist Investor Is Interested in CVS; We Take a Look
We also chat about Uber and its quest to become an everything app. 
Via The Motley Fool
This Morgan Stanley Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Via Benzinga
Domino's Pizza To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Texas Attorney General Sues Insulin Manufacturers and Pharmacy Benefit Managers Over Price-Fixing Conspiracy That Increased Prices by 1,000%
Texas Attorney General Ken Paxton sues major insulin manufacturers and PBMs, accusing them of conspiring to inflate insulin prices by as much as 1,000%, violating Texas law and harming diabetes... 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Is CVS Health Stock a Buy?
It's been a year to forget for the healthcare company. 
Via The Motley Fool
Humana Stock Dives On Medicare Ratings; UnitedHealth Tries To Bounce
Humana Medicare Advantage plans are getting a big star-ratings cut. 
Via Investor's Business Daily
CVS Health Mulls Split Of Retail And Insurance Divisions To Address Financial Challenges: Report
CVS Health explores splitting its retail and insurance units to address investor concerns and financial challenges. The potential breakup could unwind the $70 billion Aetna acquisition made in 2017. 
Via Benzinga
Instacart Is Revolutionizing Groceries: Why It's Time to Invest
It can be confusing, but Maplebear Inc. (NASDAQ: CART) is better known as Instacart, the world's largest online grocery marketplace. 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Apple, Nio, CVS Health, Stellantis, Tesla: Why These 5 Stocks Are On Investors' Radars Today
U.S. markets closed Monday slightly higher, with the Dow Jones Industrial Average edging up 0.04% to 42,330.15. 
Via Benzinga
Topics Stocks
Exposures US Equities
CVS Health in Focus as Activist Investor Prepares for High-Level Talks
CVS Health is under pressure from hedge fund Glenview Capital as the company grapples with stock price drops, financial struggles with Medicare, and legal scrutiny of its pharmacy-benefit unit. 
Via Benzinga
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Here’s Why Surgery Partners Could Be the Next Hot Takeover
Surgery Partners is the third-largest operator of ambulatory surgery centers (ASCs) in the United States, with over 200 locations. 
Via MarketBeat
Are CVS Health, Cigna, and UnitedHealth Group Stocks Bad News Buys With the FTC's PBM Crackdown?
The FTC is going after these PBMs. Is this an opportunity for investors? 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.